IP Library Granted Patent US 7,670,808
Granted Patent B2
US 7,670,808 · App. 10/821,583 · Granted Mar 2, 2010

Nucleic acid modifying enzymes

Assignee: Bio-Rad Laboratories, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,808
App. No.
10/821,583
Granted
Mar 2, 2010
Kind
B2
Abstract

This invention provides for an improved generation of novel nucleic acid modifying enzymes. The improvement is the fusion of a sequence-non-specific nucleic-acid-binding domain to the enzyme in a manner that enhances the ability of the enzyme to bind and catalytically modify the nucleic acid.

Claims (33)

1. A method of amplifying a 5kb or longer subsequence of a target nucleic acid in an aqueous solution using a polymerase chain reaction, the method comprising:

(i) contacting the target nucleic acid with a DNA polymerase comprising a sequence-non-specific double-stranded nucleic-acid-binding domain that comprises an amino acid sequence that has at least 75% identity to the amino acid sequence of SEQ ID NO:2 joined to a DNA polymerase domain with error-correcting activity, where the sequence non-specific double-stranded nucleic-acid-binding domain enhances the processivity of the DNA polymerase domain compared to an identical DNA polymerase domain not having the sequence non-specific double-stranded nucleic acid binding domain; and

wherein the solution is of a composition that permits the sequence non-specific double-stranded nucleic acid binding domain to bind to the target nucleic acid and the DNA polymerase domain to extend a primer that is hybridized to the target nucleic acid sequence to a length of 5 kb or longer;

(ii) incubating the solution using a polymerase chain reaction temperature profile that amplifies the 5 kb or longer subsequence.

2. The method of claim 1 , wherein the polymerase domain has thermally stable polymerase activity.

3. The method of claim 1 , wherein the polymerase domain comprises a Pyrococcus polymerase domain.

4. The method of claim 1 wherein the sequence-non-specific double-stranded nucleic-acid-binding domain has at least 85% identity to SEQ ID NO:2.

5. The method of claim 1 wherein the sequence-non-specific double-stranded nucleic-acid-binding domain has at least 90% identity to SEQ ID NO:2.

6. The method of claim 1 wherein the sequence-non-specific double-stranded nucleic-acid-binding domain comprises the amino acid sequence of SEQ ID NO:2.

7. A method of amplifying a subsequence of a target nucleic acid in an aqueous solution using a polymerase chain reaction, the method comprising:

contacting the target nucleic acid with a DNA polymerase comprising a sequence-non-specific double-stranded nucleic-acid-binding domain that comprises an amino acid sequence that has at least 75% identity to the amino acid sequence of SEQ ID NO:2 joined to a DNA polymerase domain with error-correcting activity, where the sequence non-specific nucleic-acid-binding domain enhances the processivity of the DNA polymerase domain compared to an identical DNA polymerase domain not having the sequence non-specific double-stranded nucleic acid binding domain; and

wherein the solution comprises 10 5 or fewer copies/ml of the target nucleic acid and is of a composition that permits the sequence non-specific double-stranded nucleic acid binding domain to bind to the target nucleic acid and the DNA polymerase domain to extend a primer that is hybridized to the target nucleic acid sequence;

(ii) incubating the solution using a polymerase chain reaction temperature profile that amplifies the subsequence.

8. The method of claim 7 wherein the polymerase domain has thermally stable polymerase activity.

9. The method of claim 7 wherein the polymerase domain comprises a Pyrococcus polymerase domain.

10. The method of claim 7 wherein the sequence-non-specific double-stranded nucleic-acid-binding domain has at least 85% identity to SEQ ID NO:2.

11. The method of claim 7 wherein the sequence-non-specific double-stranded nucleic-acid-binding domain has at least 90% identity to SEQ ID NO:2.

12. The method of claim 7 , wherein the sequence-non-specific double-stranded nucleic-acid-binding domain comprises the amino acid sequence of SEQ ID NO:2.

13. A method of amplifying a target nucleic acid in an aqueous solution, the method comprising:

(i) contacting the target nucleic acid with a DNA polymerase comprising a sequence non-specific double-stranded nucleic acid binding domain joined to a DNA polymerase domain, wherein the sequence non-specific double-stranded nucleic acid binding domain comprises an amino acid sequence that has at least 75% identity to the amino acid sequence of SEQ ID NO:2, where the presence of the sequence non-specific double-stranded nucleic acid binding domain enhances the processivity of the DNA polymerase domain compared to an identical DNA polymerase domain not having the sequence non-specific double-stranded nucleic acid binding domain; and

wherein the solution is of a composition that permits the sequence non-specific double-stranded nucleic acid binding domain to bind to the target nucleic acid and the polymerase domain to extend a primer that is hybridized to the target nucleic acid sequence;

(ii) incubating the solution such that the primer is extended, thereby amplifying the target nucleic acid.

14. The method of claim 13 , wherein the sequence-non-specific double-stranded nucleic-acid-binding domain has at least 85% identity to SEQ ID NO:2.

15. The method of claim 13 , wherein the sequence-non-specific double-stranded nucleic-acid-binding domain has at least 90% identity to SEQ ID NO:2.

16. The method of claim 13 , wherein the sequence-non-specific double-stranded nucleic-acid-binding domain comprises the amino acid sequence of SEQ ID NO:2.

17. The method of claim 13 , wherein the polymerase domain comprises a family A polymerase domain.

18. The method of claim 13 , wherein the polymerase domain comprises a family B polymerase domain.

19. The method of claim 13 , wherein the polymerase domain is thermostable.

20. The method of claim 13 , wherein the polymerase domain is a Thermus polymerase domain or a Pyrococcus polymerase domain.

21. A method of claim 13 , wherein the sequence non-specific double-stranded nucleic acid binding domain comprises an amino acid sequence that has at least 75% sequence identity to the Sac7d sequence set forth in amino acids 7-71 of SEQ ID NO:10.

22. The method of claim 19 , wherein the sequence non-specific double-stranded nucleic acid binding domain comprises an amino acid sequence that has at least 85% sequence identity to the Sac7d sequence set forth in amino acids 7-71 of SEQ ID NO:10.

23. The method of claim 20 , wherein the sequence non-specific double-stranded nucleic acid binding domain comprises an amino acid sequence that has at least 90% sequence identity to the Sac7d sequence set forth in amino acids 7-71 of SEQ ID NO:10.

24. The method of claim 13 , wherein the sequence non-specific nucleic-acid-binding domain is Sac7d.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2006
From: MJ BIOWORKS, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 017706/0891 →
Continuity (4)
Division 0987035300 · May 30, 2001
Continuation In Part 0964095800 · Aug 16, 2000
Provisional Application 6020756700 · May 26, 2000
Related Publication 20040191825A1 · Sep 30, 2004